iShares STOXX Europe 600 Health Care UCITS ETF (DE) (VIE:EX31)
Austria · Delayed Price · Currency is EUR 112.58
+1.54 (1.39%)
At close: Sep 22, 2026
VIE:EX31 Holdings Information
VIE:EX31 is an equity ETF with a total of 65 individual holdings. The top holdings are Roche Holding AG stock at 16.68%, Novartis AG at 14.33%, AstraZeneca at 13.91%, Novo Nordisk at 6.85%, and GSK plc at 5.52%.
Total Holdings
65
Top 10 Percentage
73.91%
Asset Class
Equity
ETF Category
Health Care
Assets
695.36M
PE Ratio
19.05
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SWX: ROP | Roche Holding AG | 16.68% |
| 2 | SWX: NOVN | Novartis AG | 14.33% |
| 3 | LON: AZN | AstraZeneca PLC | 13.91% |
| 4 | CPH: NOVO.B | Novo Nordisk A/S | 6.85% |
| 5 | LON: GSK | GSK plc | 5.52% |
| 6 | EPA: SAN | Sanofi | 5.11% |
| 7 | EBR: ARGX | argenx SE | 3.34% |
| 8 | ETR: BAYN | Bayer Aktiengesellschaft | 2.95% |
| 9 | EPA: EL | EssilorLuxottica Société anonyme | 2.72% |
| 10 | SWX: LONN | Lonza Group AG | 2.51% |
| 11 | LON: HLN | Haleon plc | 2.16% |
| 12 | SWX: GALD | Galderma Group AG | 2.00% |
| 13 | SWX: SDZ | Sandoz Group AG | 2.00% |
| 14 | SWX: ALC | Alcon Inc. | 1.74% |
| 15 | EBR: UCB | UCB SA | 1.61% |
| 16 | CPH: NSIS.B | Novozymes A/S | 1.23% |
| 17 | CPH: GMAB | Genmab A/S | 1.16% |
| 18 | FSNUF | Fresenius SE & Co. KGaA | 1.14% |
| 19 | AMS: PHIA | Koninklijke Philips N.V. | 1.06% |
| 20 | ETR: MRK | Merck KGaA | 1.05% |
| 21 | ETR: SHL | Siemens Healthineers AG | 0.87% |
| 22 | SWX: SOON | Sonova Holding AG | 0.76% |
| 23 | SWX: STMN | Straumann Holding AG | 0.74% |
| 24 | LON: SN | Smith & Nephew plc | 0.65% |
| 25 | STO: SOBI | Swedish Orphan Biovitrum AB (publ) | 0.57% |
As of Sep 21, 2026